Market Insight - Influenza: the avoidable killer
This article was originally published in Scrip
Despite the long-standing availability of vaccines, seasonal influenza still accounts for 300,000-500,000 deaths annually worldwide,1 and creates considerable economic strain and burden on healthcare providers, during the intense four- to five-month influenza season each year. Not only do challenges remain in the reduction of morbidity and mortality caused by seasonal influenza, a real threat of pandemic influenza is today a genuine and increasing concern. The current environment surrounding influenza is therefore one of significant investment, regulatory and policy change, and global co-operation efforts in an attempt to minimise the burden of seasonal influenza and maximise preparedness for a pandemic.